Apr 03, 2017 12:01 pm UTC| Business
Accelerated Timelines for Both Top-line IGNITE4 Eravacycline Data and MAA filing in Europe; Both Now Expected in 3Q 2017 IGNITE4 Results to Support U.S. NDA Filing for IV Eravacycline in cIAI WATERTOWN, Mass., April ...
Apr 03, 2017 12:01 pm UTC| Business
Accelerated Timelines for Both Top-line IGNITE4 Eravacycline Data and MAA filing in Europe; Both Now Expected in 3Q 2017 IGNITE4 Results to Support U.S. NDA Filing for IV Eravacycline in cIAI WATERTOWN, Mass., April ...
Apr 03, 2017 12:01 pm UTC| Business
OMAHA, Neb., April 03, 2017 -- On March 31, 2017, America First Multifamily Investors, L.P. (NASDAQ:ATAX) (“the Partnership”) entered into a follow-on Subscription Agreement with an existing investor in the Preferred...
Apr 03, 2017 12:01 pm UTC| Business
OMAHA, Neb., April 03, 2017 -- On March 31, 2017, America First Multifamily Investors, L.P. (NASDAQ:ATAX) (“the Partnership”) entered into a follow-on Subscription Agreement with an existing investor in the Preferred...
Apr 03, 2017 12:01 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., April 03, 2017 -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a biopharmaceutical company developing meaningful therapies for patients with severe and life-threatening diseases that have been...
Apr 03, 2017 12:01 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., April 03, 2017 -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics,...
Apr 03, 2017 12:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., April 03, 2017 -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics,...
US–India Trade Talks Race Toward USD 500 Billion Goal